Viewing Study NCT00531050

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-05-09 @ 6:16 AM
Study NCT ID: NCT00531050
Status: COMPLETED
Last Update Posted: 2012-05-23
First Post: 2007-09-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COPD View
None cycle ergometry View
None exercise testing View
None spirometry View
None cardiovascular View
None salbutamol View
None indacaterol View
None chronic obstructive pulmonary disease View